Follow
Yuhao Xie
Title
Cited by
Cited by
Year
Signaling pathways and therapeutic interventions in gastric cancer
ZN Lei, QX Teng, Q Tian, W Chen, Y Xie, K Wu, Q Zeng, L Zeng, Y Pan, ...
Signal transduction and targeted therapy 7 (1), 358, 2022
802022
Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers
J Jin, Y Xie, JS Zhang, JQ Wang, SJ Dai, W He, SY Li, CR Ashby Jr, ...
Drug Resistance Updates 67, 100929, 2023
312023
Resistance-proof antimicrobial drug discovery to combat global antimicrobial resistance threat
A Upadhayay, J Ling, D Pal, Y Xie, FF Ping, A Kumar
Drug Resistance Updates 66, 100890, 2023
312023
Nivolumab and relatlimab for the treatment of melanoma.
XY Chen, YD Li, Y Xie, LQ Cao, CR Ashby Jr, H Zhao, ZS Chen
Drugs of Today (Barcelona, Spain: 1998) 59 (2), 91-104, 2023
52023
Tebentafusp: a novel drug for the treatment of metastatic uveal melanoma.
Z Wang, Y Xie, JQ Wang, Y Cheng, J Fleishman, ZS Chen, Y Chen
Drugs of Today (Barcelona, Spain: 1998) 59 (3), 179-193, 2023
22023
Amivantamab: a monoclonal EGFR-MET bispecific antibody for EGFR exon 20 insertion in non-small cell lung cancer.
Y Xie, Q Lu, JQ Wang, L Bo, CR Ashby Jr, ZS Chen
Drugs of Today (Barcelona, Spain: 1998) 58 (8), 389-398, 2022
22022
The role of ABCC10/MRP7 in anti-cancer drug resistance and beyond
DQ Chen, Y Xie, LQ Cao, JS Fleishman, Y Chen, T Wu, DH Yang
Drug Resistance Updates, 101062, 2024
12024
A cycloruthenated complex, ruthenium (II) Z (RuZ) overcomes in vitro and in vivo multidrug resistance in cancer cells: A pivotal breakthrough
L Cao, Y Xie, Z Chen, CR Ashby
Journal of Translational Internal Medicine 11 (2), 95-97, 2023
12023
Therapeutic evolution in HR+/HER2-breast cancer: from targeted therapy to endocrine therapy
LQ Cao, H Sun, Y Xie, H Patel, L Bo, H Lin, ZS Chen
Frontiers in Pharmacology 15, 1340764, 2024
2024
Zandelisib. Phosphatidylinositol 3-kinase δ (PI3Kδ) inhibitor, Treatment of B-cell lymphomas
Q Lu, Y Xie, Z Zhu, G Huang, CR AshbyJr, ZS Chen
Drugs of the Future 47 (8), 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–10